Astrid Edland

885 total citations
16 papers, 509 citations indexed

About

Astrid Edland is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Astrid Edland has authored 16 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 5 papers in Rheumatology and 3 papers in Neurology. Recurrent topics in Astrid Edland's work include Multiple Sclerosis Research Studies (12 papers), Powdery Mildew Fungal Diseases (3 papers) and Peripheral Neuropathies and Disorders (3 papers). Astrid Edland is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Powdery Mildew Fungal Diseases (3 papers) and Peripheral Neuropathies and Disorders (3 papers). Astrid Edland collaborates with scholars based in Norway, Sweden and Denmark. Astrid Edland's co-authors include Karl O. Nakken, Harald Nyland, Trond Riise, Gunnar Hansen, M. Grønning, Elisabeth Gulowsen Celius, Jeanette Koht, Marte Syvertsen, Jan Larsen and Rune Midgard and has published in prestigious journals such as Neurology, The Lancet Neurology and Journal of Clinical Epidemiology.

In The Last Decade

Astrid Edland

16 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Astrid Edland Norway	12	289	123	118	115	74	16	509
Anton Vladić Croatia	12	452 1.6×	51 0.4×	218 1.8×	141 1.2×	45 0.6×	26	726
Takafumi Hosokawa Japan	11	132 0.5×	31 0.3×	202 1.7×	72 0.6×	12 0.2×	32	388
Gianna Costa Italy	13	219 0.8×	20 0.2×	60 0.5×	69 0.6×	28 0.4×	24	505
Ulla Engel Denmark	13	88 0.3×	98 0.8×	37 0.3×	20 0.2×	17 0.2×	30	488
R. Schwendimann United States	10	65 0.2×	20 0.2×	69 0.6×	39 0.3×	30 0.4×	27	323
Katsuhiko Oguro Japan	10	97 0.3×	90 0.7×	46 0.4×	193 1.7×	83 1.1×	19	653
Graziella Callari Italy	12	169 0.6×	34 0.3×	242 2.1×	46 0.4×	6 0.1×	18	472
Simona Toscano Italy	11	233 0.8×	20 0.2×	148 1.3×	61 0.5×	7 0.1×	24	422
Naeem Mahfooz United States	7	150 0.5×	26 0.2×	45 0.4×	81 0.7×	18 0.2×	11	302
V. Argentiero Italy	9	70 0.2×	28 0.2×	129 1.1×	34 0.3×	15 0.2×	16	523

Countries citing papers authored by Astrid Edland

Since Specialization

Citations

This map shows the geographic impact of Astrid Edland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Edland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Edland more than expected).

Fields of papers citing papers by Astrid Edland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Edland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Edland. The network helps show where Astrid Edland may publish in the future.

Co-authorship network of co-authors of Astrid Edland

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Edland. A scholar is included among the top collaborators of Astrid Edland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Edland. Astrid Edland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wesnes, Kristin, Iman Brouwer, Stig Wergeland, et al.. (2022). The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 9(5). 7 indexed citations

Wesnes, Kristin, Kjell‐Morten Myhr, Trond Riise, et al.. (2021). Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. Multiple Sclerosis and Related Disorders. 50. 102801–102801. 15 indexed citations

Broch, Line, et al.. (2020). Anafylaktisk reaksjon ved bruk av MR-kontrastmiddel. Tidsskrift for Den norske legeforening. 140(8). 1 indexed citations

Simonsen, Cecilia Smith, Gunnar Hansen, Fredrik Piehl, & Astrid Edland. (2016). Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 2. 2451078272–2451078272. 4 indexed citations

Syvertsen, Marte, Gunnar Hansen, Astrid Edland, et al.. (2016). Prevalence of juvenile myoclonic epilepsy in people <30 years of age—A population‐based study in Norway. Epilepsia. 58(1). 105–112. 32 indexed citations

Edland, Astrid, et al.. (2016). High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud. Acta Neurologica Scandinavica. 135(4). 412–418. 24 indexed citations

Syvertsen, Marte, et al.. (2015). Prevalence and etiology of epilepsy in a Norwegian county—A population based study. Epilepsia. 56(5). 699–706. 72 indexed citations

Ziemssen, Tjalf, Ovidiu Băjenaru, Adriana Carrá, et al.. (2014). A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial. Journal of Neurology. 261(11). 2101–2111. 31 indexed citations

Nakken, Karl O., et al.. (2014). Multiple sclerosis and seizures: incidence and prevalence over 40 years. Acta Neurologica Scandinavica. 130(6). 368–373. 33 indexed citations

10.

Sørensen, Per Soelberg, Jan Lycke, Juha-Pekka Erälinna, et al.. (2011). Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial. The Lancet Neurology. 10(8). 691–701. 84 indexed citations

11.

Edland, Astrid, et al.. (2009). Epidemiology of multiple sclerosis in the county of Vestfold, eastern Norway: incidence and prevalence calculations. Acta Neurologica Scandinavica. 93(2-3). 104–109. 12 indexed citations

12.

Midgard, Rune, Eystein Glattre, M. Grønning, et al.. (2009). Multiple sclerosis and cancer in Norway A retrospective cohort study. Acta Neurologica Scandinavica. 93(6). 411–415. 51 indexed citations

13.

Myhr, Kjell‐Morten, Trond Riise, Finn Lilleås, et al.. (1999). Interferon-α2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Neurology. 52(5). 1049–1049. 42 indexed citations

14.

Midgard, Rune, Eystein Glattre, M. Grønning, et al.. (1995). Multiple sclerosis and cancer in Norway. A retrospective cohort study. Journal of Neuroimmunology. 56-63. 69–69. 6 indexed citations

15.

Tvedt, Bjørn, et al.. (1991). Delayed neuropsychiatric sequelae after acute hydrogen sulfide poisoning: affection of motor function, memory, vision and hearing. Acta Neurologica Scandinavica. 84(4). 348–351. 44 indexed citations

16.

Riise, Trond, M. Grønning, Johan A. Aarli, et al.. (1988). Prognostic factors for life expectancy in multiple sclerosis analysed by. Journal of Clinical Epidemiology. 41(10). 1031–1036. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact